RxDoctor Payments Data

Bridget Hopson, NP

Nurse Practitioner · Memphis, TNNPI 1477005429

Payments from drug & device makers

$5,211in general payments, 2019–2025

Across 282 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$455
  • AbbVie$414
  • Astellas Pharma US Inc$340
  • Boehringer Ingelheim$283
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,11198%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,211 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$16,193
Medicare patients
176
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin61$73,123
MounjaroTirzepatide28$31,053
EliquisApixaban42$29,069
JanuviaSitagliptin Phosphate25$22,587
LinzessLinaclotide16$19,507
OzempicSemaglutide13$13,416
BelsomraSuvorexant19$10,942
FarxigaDapagliflozin Propanediol14$10,597
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$9,487
Albuterol Sulfate HfaAlbuterol Sulfate67$1,989
Amlodipine Besylate281$1,828
Gabapentin138$1,810
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,748
Atorvastatin Calcium157$1,688
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide20$1,652

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$283$73,12361 claims
MerckJanuvia, Belsomra$150$33,52944 claims
Lilly USA, LLCMounjaro$455$31,05328 claims
PfizerEliquis$49$29,06942 claims
AbbVieLinzess$414$19,50716 claims
Novo NordiskOzempic$1,154$13,41613 claims
AstraZenecaFarxiga$1,009$10,59714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →